Reply to Giulia I. Lane and Badrinath Konety's Letter to the Editor re: Bimal Bhindi, Igor Frank, Ross J. Mason, et al. Oncologic Outcomes for Patients with Residual Cancer at Cystectomy Following Neoadjuvant Chemotherapy: A Pathologic Stage-matched Analysis. Eur Urol 2017;72:660-4

Bimal Bhindi, Stephen A. Boorjian

Research output: Contribution to journalArticle

Original languageEnglish (US)
JournalEuropean Urology
DOIs
StateAccepted/In press - Jan 1 2017

Fingerprint

Cystectomy
Residual Neoplasm
Drug Therapy

ASJC Scopus subject areas

  • Urology

Cite this

@article{8dcbb3b178d84b4689552f3419c51c92,
title = "Reply to Giulia I. Lane and Badrinath Konety's Letter to the Editor re: Bimal Bhindi, Igor Frank, Ross J. Mason, et al. Oncologic Outcomes for Patients with Residual Cancer at Cystectomy Following Neoadjuvant Chemotherapy: A Pathologic Stage-matched Analysis. Eur Urol 2017;72:660-4",
author = "Bimal Bhindi and Boorjian, {Stephen A.}",
year = "2017",
month = "1",
day = "1",
doi = "10.1016/j.eururo.2017.10.017",
language = "English (US)",
journal = "European Urology",
issn = "0302-2838",
publisher = "Elsevier",

}

TY - JOUR

T1 - Reply to Giulia I. Lane and Badrinath Konety's Letter to the Editor re

T2 - Bimal Bhindi, Igor Frank, Ross J. Mason, et al. Oncologic Outcomes for Patients with Residual Cancer at Cystectomy Following Neoadjuvant Chemotherapy: A Pathologic Stage-matched Analysis. Eur Urol 2017;72:660-4

AU - Bhindi, Bimal

AU - Boorjian, Stephen A.

PY - 2017/1/1

Y1 - 2017/1/1

UR - http://www.scopus.com/inward/record.url?scp=85032739208&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032739208&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2017.10.017

DO - 10.1016/j.eururo.2017.10.017

M3 - Article

AN - SCOPUS:85032739208

JO - European Urology

JF - European Urology

SN - 0302-2838

ER -